Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2023 |
|---|---|---|---|---|
| Total reported revenue | — | — | — | 3.8B |
| Cost of revenue | — | — | — | 1.6B |
| Gross profit | — | — | — | 2.2B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | 886.6M |
| Other operating expenses | — | — | — | 188.4M |
| Operating income | — | — | — | -18.7M |
| Non operating interest income | ||||
| Income | — | — | — | 32.8M |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | — | — | — | 14.1M |
| Tax provision | — | — | — | 34.4M |
| Net income | — | — | — | -20.3M |
| Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | 1.1B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | 38.9M |
| Preferred stock dividends | — | — | — | 0 |